Similarly, mainly NPC cell, but not CD68+ CD86+ M1 and CD68+ CD206+ M2 macrophage-derived PD-L1 protein was increased in tumor samples from responders (Fig. 3b and Supplementary Fig. 1). The gene discussed is CD86; the disease is nasopharyngeal carcinoma.